Shanghai Yuanvore Medicine Technology Co., Ltd. is a regenerative medicine company specializing in the development and application of iPSC (induced pluripotent stem cells) technology.

With its unique unlimited proliferation ability and developmental totipotency, iPSC provides unlimited possibilities for regenerative medicine. Together with the world's leading team of iPSC experts, we are committed to creating the "Yuanwu Program"-- to achieve a global breakthrough in the industrialization of iPSC induction, differentiation and amplification, and to carry out innovative research and development around the high incidence of clinical diseases such as immune system, metabolic system and nervous system, to build an efficient, stable and accurate iPSC technology platform for the treatment of chronic diseases of human beings, and to create a road of regeneration for human life and health.

We believe that better cell therapy comes from better cells. Yuanvore Medicine will build a "super cell bank" to ensure that the quantity, quality, purity and repeatability of iPSC meet the requirements of academic research, drug discovery and cell therapy development with strict quality control and innovative transformation technology.

We combine stem cell biology with genomic methods to study restorative therapy for patients. Take the clinical unmet demand for severe chronic diseases as the core research and development products to provide reliable quality and affordable iPSC treatment products for patients around the world.